← Biology and medicine this week · 16 November 2026 · 5 min read
Biology and medicine this week: New jobs for cells, enzymes and genes
Fish placentas, bacterial metabolism and experimental treatments reveal how biological possibilities emerge when existing machinery is repurposed or its constraints are eased.
How to check the findings and keep reading? Illustrated guide
How these papers were chosen among the week's 1393 papers
All 1393 papers of the week whose main category is in this field were read, title and start of the abstract, and 55 were kept. They were then ordered by what can be counted: how many research profiles of our readers they come close to, whether a rising topic of the field includes them, and how many categories they were posted in. The abstracts of the first 40 were read in full to choose these, no more than two from one category and one per team.
The 8 numbers of the text were checked against the abstracts. 23 statements on what the papers found were looked for word for word in their abstracts.
Sources: bioRxiv, medRxiv.
Before the placenta, a new maternal cell #
How does an organ evolve? Live-bearing fish offer an unusually accessible answer because placentas have arisen independently at least nine times within the family Poeciliidae. Comparing pairs of closely related species with and without placentas, researchers traced a maternal cell type to the family’s common ancestor. This cell appears to have borrowed part of an existing ovarian gene-regulation programme and likely helped make live birth possible by allowing mothers to retain eggs.
The preprint then follows a second act: in all five placental origins examined, that same maternal cell type and the embryonic yolk sac were independently recruited into a placenta. Similar functions, including lipid metabolism and vesicle-mediated transport, evolved largely through changes in different genes. The broader lesson is that repeated evolution need not mean repeated genetic instructions: a shared cellular starting point can support similar organs through different molecular routes.
-
A new cell type facilitated live-bearing and multiple independent origins of placentation in fish
D. Safian, …, M. Cardoso-Moreira (6 authors) · bioRxiv · Observation · Preprint, not yet peer reviewed
Rests on: pairs of sister species with and without a placenta
Main limit: The proposed role of the new maternal cell type in enabling live birth remains an evolutionary inference, described as likely rather than directly demonstrated.
Read with it: The genomics of placenta evolution in livebearing fish (2022) · Repeated independent origins of the placenta reveal convergent and divergent organ evolution within a single fish family (Poeciliidae) (Science Advances, 2023)
Worth knowing?
Prepare a press kit Premium+ →
A bacterial enzyme’s suppressed second career #
An enzyme can do more than its usual job, and evolution can exploit that spare capacity. Researchers grew Escherichia coli unable to break down hexose sugars on glucose and recovered mutations in fruK, which encodes a sugar-phosphorylating enzyme. Genetic reconstruction and expression measurements identified an altered, strongly overproduced FruK as the basis of renewed growth. Purified variants could act on an alternative substrate needed for glycolysis; the best showed a ~170-fold improvement in catalytic efficiency over the original enzyme.
Crystal structures pointed to an active-site lysine that normally excludes the alternative substrate. A different bacterium, Corynebacterium glutamicum, evolved the same adaptation, suggesting this is not an isolated biochemical trick. Why retain the restriction? The authors propose that it prevents metabolic flux from interfering with gene regulation. That explanation remains a proposal, but the experiments show how a seemingly missing metabolic capability can sit close at hand, constrained rather than wholly absent.
-
Gain-of-function mutations in 1-phosphofructokinase (FruK) re-establish glycolysis in bacteria
B. B. Dronsella, …, A. Bar-Even (12 authors) · bioRxiv · Experiment · Preprint, not yet peer reviewed
Rests on: Reverse engineering, gene deletions and transcript quantification
Main limit: The explanation that the active-site residue separates glycolytic flux from transcriptional control is proposed rather than established.
Read with it: Fructose-1-kinase has pleiotropic roles in Escherichia coli (Journal of Biological Chemistry, 2024) · Investigation of glycolysis in Bacillus subtilis (eDiss (Georg-August-Universität Göttingen), 2010)
Worth knowing?
Prepare a press kit Premium+ →
Fitting a mitochondrial rescue into a viral delivery vehicle #
Gene replacement is not simply a matter of supplying a healthy gene: the package must fit its delivery vehicle. LRPPRC, whose disruption can cause severe mitochondrial disease, is difficult to accommodate in an adeno-associated viral vector alongside conventional regulatory elements. Researchers engineered compact vectors carrying human or mouse LRPPRC and injected them into mice lacking the gene in heart and skeletal muscle.
The treatment restored cardiac protein expression, preserved mitochondrial energy production, prevented cardiomyopathy and markedly prolonged survival. Skeletal muscle recovery was only partial, an important reminder that successful delivery and rescue can differ between tissues. This preprint provides an animal proof of concept for overcoming a packaging barrier, not evidence of benefit in patients or of correction across the disease’s neurological, liver and muscle manifestations.
-
LRPPRC gene replacement therapy preserves cardiac function and prevents premature death in a mouse model of mitochondrial disease
S. Zanin, …, B. Ruzzenente (10 authors) · bioRxiv · Experiment · Preprint, not yet peer reviewed
Rests on: heart and skeletal muscle-specific Lrpprc knockout mice
Main limit: Skeletal muscle rescue was partial despite prevention of fatal cardiac dysfunction.
Read with it: Hepatic gene replacement improves energy metabolism and survival in a mouse model of neonatal mitochondrial disease GRACILE syndrome (Molecular Therapy, 2026) · Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency (Pharmaceutics, 2023)
Worth knowing?
Prepare a press kit Premium+ →
Turning uncertain heart variants into usable evidence #
A genetic result can leave a patient with uncertainty rather than an explanation. A French nationwide study tackled this problem for KCNH2, a gene associated with long QT syndrome, by functionally profiling 303 variants, including 201 variants of uncertain significance. Automated electrical recordings and membrane-trafficking assays fed into computational models of cardiac repolarization, which were then compared with patient electrocardiograms and estimates of disease penetrance.
Looking beyond electrical current amplitude exposed defects that a simpler assay could miss. After calibrating the functional results against established benign and pathogenic variants, the researchers reclassified 64 of 201 uncertain variants. The accompanying HAMMER database makes the work a resource beyond the immediate study. This clinical preprint illustrates how laboratory measurements can strengthen genetic interpretation, while also showing why a channel defect cannot perfectly predict an individual’s heart rhythm: incomplete penetrance remains part of the picture.
-
Nationwide Functional Profiling Enables Clinical Reclassification of KCNH2 Variants in the French LQT2 Population
B. Ribeiro de Oliveira, …, M. De Waard (23 authors) · medRxiv · Clinical study · Preprint, not yet peer reviewed
Rests on: standardized high-throughput automated patch-clamp electrophysiology and complementary membrane trafficking assays
Main limit: Modeled repolarization phenotypes did not fully agree with patient findings, with some discrepancies consistent with incomplete penetrance.
Read with it: Functional evaluation of gene mutations in Long QT Syndrome: strength of evidence from in vitro assays for deciphering variants of uncertain significance (Journal of Congenital Cardiology, 2020) · Interpreting the actionable clinical role of rare variants associated with short QT syndrome (Human Genetics, 2024)
Worth knowing?
Prepare a press kit Premium+ →
Radiation protection may also be a repair programme #
Ultra-high dose rate radiotherapy, known as FLASH, can spare normal tissue, but the explanation may extend beyond the initial radiation injury. In mice receiving abdominal irradiation, researchers combined single-cell gene-expression measurements, computational analyses and interventions in living animals to examine intestinal recovery. Compared with conventional irradiation, FLASH preserved intestinal stem cells and absorptive epithelial cells, alongside changes in macrophages and reduced inflammatory T-cell responses.
A candidate connection was WNT4 signalling between macrophages and intestinal stem cells. Increasing Wnt4 signalling after conventional irradiation promoted regeneration of intestinal crypts, supporting a functional role for this repair pathway. The preprint suggests that radiation timing can reshape the immune environment in which tissue heals. It does not, however, establish that WNT4 is necessary for FLASH’s protective effect: helping conventional-radiation recovery is not the same as proving what FLASH depends on.
-
FLASH radiotherapy drives intestinal regeneration via macrophage-derived WNT4 signaling and attenuated T-cell inflammation
Y. ZHU, …, Q. Fu (17 authors) · bioRxiv · Experiment · Preprint, not yet peer reviewed
Rests on: single-cell transcriptomics, trajectory analysis, cell-cell communication inference, and in vivo perturbation experiments
Main limit: Wnt4 augmentation promoted regeneration after conventional irradiation, but the abstract does not report a loss-of-function test establishing its necessity for FLASH protection.
Worth knowing?
Prepare a press kit Premium+ →
Smaller endocrine clusters cope better without blood vessels #
Encapsulation could protect transplanted insulin-producing cells from immune-cell contact without immunosuppression, but the protective barrier also blocks blood vessels from entering. Researchers addressed that trade-off by changing the cells’ arrangement rather than relying on the device alone. They fragmented native pancreatic islets into small endocrine clusters and allowed them to recover in culture. Under hypoxic conditions, these engineered clusters retained viability of >90%, compared with 49% for native islets.
Placed in thin alginate-based devices under the skin of immunocompetent diabetic mice, rat-derived clusters maintained glycemic control for over 5 weeks. Retrieved clusters showed less central cell death than native islets. The result makes a broader engineering point: adapting living cargo to a device’s physical limits can matter as much as improving the device. It remains a preclinical demonstration, with partial protection against immune attack and limited follow-up rather than established long-term transplantation durability.
-
Engineered endocrine objects tolerate hypoxia in macroencapsulation devices and enable subcutaneous engraftment in diabetic mice
K. Wang, …, M. Ma (9 authors) · bioRxiv · Experiment · Preprint, not yet peer reviewed
Rests on: immunocompetent diabetic mice
Main limit: The reported glycemic control over 5 weeks does not establish long-term graft durability.
Read with it: Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes (Advanced Science, 2021) · An in vitro Perfused Macroencapsulation Device to Study Hemocompatibility and Survival of Islet-Like Cell Clusters (Frontiers in Bioengineering and Biotechnology, 2021)
Worth knowing?
Prepare a press kit Premium+ →
These preprints share a theme of biological possibility bounded by context. A cell type becomes material for a new organ; an enzyme acquires a metabolic role; a therapeutic gene needs a workable package; transplanted cells need a tolerable physical environment. Even genetic diagnosis and radiation recovery become clearer when studied beyond a single molecular measurement. Across these fields, the useful question is not only what a biological component does, but what allows—or prevents—it from doing something else.
Rising in this field
- Reading gene activity one RNA version at a time bioRxiv · ×10.7 compared with usual · 8 papers from 8 teams
- Finding genes whose activity changes bioRxiv · Bioinformatics · ×5.6 compared with usual · 11 papers from 11 teams
- Unusual T cells at the crossroads of immunity and inflammation bioRxiv · ×9.3 compared with usual · 7 papers from 6 teams
Was this letter useful to you?
Thank you: your answers help choose the papers of the next letters.
Written by AI from the 1483 papers of the week in this field. Most are preprints, not yet peer reviewed: the text says what their authors report.
Get one letter by email every week with a free account, all of them with Premium. Create a free account